×

Estrogen beta receptor agonists to prevent or reduce the severity of cardiovascular disease

  • US 20100152144A1
  • Filed: 02/19/2010
  • Published: 06/17/2010
  • Est. Priority Date: 11/22/2002
  • Status: Abandoned Application
First Claim
Patent Images

1. A method for reducing the incidence or severity of vascular hyperreactivity in a patient in need thereof comprising administering to the patient an effective amount of a selective estrogen beta receptor agonist that has a higher relative potency for estrogen receptor beta compared to estrogen receptor alpha than that of genistein.

View all claims
  • 0 Assignments
Timeline View
Assignment View
    ×
    ×